Invivoscribe's subsidiary, LabPMM, has secured New York State (NYS) approval for the NPM1 MRD Assay to combat acute myeloid ...

BioOrbit CEO Dr Katie King said that pre-clinical studies of the crystals produced in space could start as early as 2026.

Exo has obtained 510(k) clearance for two AI-based apps that detect two common lung conditions with its Exo Iris POCUS device ...

GeneCentric Therapeutics has secured $8m in a Series C funding round for its comprehensive liquid biopsy testing system, ...